Diamminedichloropalladium(II) 13782-33-7: Your Trusted Supplier for High-Purity Catalyst

Discover the critical role of Diamminedichloropalladium(II) (CAS 13782-33-7) in modern chemical synthesis and electroplating. As a premier manufacturer and supplier, we provide high-purity palladium catalysts essential for your R&D and production needs. Explore its applications and secure your supply.

Get a Quote & Sample

Key Advantages of Sourcing Diamminedichloropalladium(II)

Exceptional Purity and Consistency

Our Diamminedichloropalladium(II) meets stringent purity standards, ensuring reliable performance in your sensitive catalytic and synthetic processes. As a dedicated manufacturer, we guarantee batch-to-batch consistency.

Versatile Catalytic Applications

This palladium compound is a vital catalyst for stereoselective alkylation of aldol reactions and solid-phase oligosaccharide synthesis. Its versatility makes it a cornerstone for advanced chemical research and development.

Reliable Supplier in China

We are your go-to supplier for Diamminedichloropalladium(II), offering competitive pricing and efficient logistics. Procure this essential chemical with confidence from a reputable manufacturer.

Applications of Diamminedichloropalladium(II)

Catalysis in Organic Synthesis

Diamminedichloropalladium(II) acts as a crucial catalyst in complex organic reactions, including stereoselective alkylation, making it indispensable for pharmaceutical intermediate synthesis.

Electroplating Industry

As a key raw material for palladium plating baths, it enables the creation of durable and aesthetically pleasing metallic coatings for electronics and jewelry.

Synthesis of Palladium Compounds

This compound serves as a foundational material for creating a wide array of other valuable palladium-based chemicals and catalysts, supporting diverse industrial needs.

N-Glycan Synthesis

It plays a role in solid-phase oligosaccharide synthesis, particularly in the preparation of N-glycans, which are important in glycobiology research and biopharmaceutical development.